About: At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens
Creator	Sullivan, Patrick Sanchez, Travis Adam, Elizabeth Guest, Jodie Hall, Eric Hardee, Isabel Shinn, Katlin Siegler, Aaron Valencia, Rachel Valentine-Graves, Mariah
Source	MedRxiv; Medline; PMC
abstract	BACKGROUND: Options to increase the ease of testing for SARS-CoV-2 infection and immune response are needed. Self-collection of diagnostic specimens at home offers an avenue to allow people to test for SARS-CoV-2 infection or immune response without traveling to a clinic or laboratory. Before this study, survey respondents indicated willingness to self-collect specimens for COVID-related tests, but hypothetical willingness can differ from post-collection acceptability after participants collect specimens. METHODS: 153 US adults were enrolled in a study of the willingness and feasibility of patients to self-collect three diagnostic specimens (saliva, oropharyngeal swab (OPS) and dried blood spot (DBS) card) while observed by a clinician through a telehealth session. After the specimens were collected, 148 participants participated in a survey about the acceptability of the collection, packing and shipping process, and their confidence in the samples collected for COVID-related laboratory testing. RESULTS: A large majority of participants (>84%) reported that collecting, packing and shipping of saliva, OPS, and DBS specimens were acceptable. Nearly nine in 10 (87%) reported being confident or very confident that the specimens they collected were sufficient for laboratory analysis. There were no differences in acceptability for any specimen type, packing and shipping, or confidence in samples by gender, age, race/ethnicity, or educational level. CONCLUSIONS: Self-collection of specimens for SARS-CoV-2 testing and preparing and shipping specimens for analysis were acceptable in a diverse group of US adults. Further refinement of materials and instructions to support self-collection of saliva, OPS and DBS specimens for COVID-related testing is needed. TRIAL REGISTRATION: No intervention was tested in this study
has issue date	2020-06-12(xsd:dateTime)
bibo:doi	10.1101/2020.06.10.20127845
bibo:pmid	32587988
has license	cc-by-nc-nd
sha1sum (hex)	4b7d38d3d1f303908fc3436c0b59b5a83d01805a
schema:url	https://doi.org/10.1101/2020.06.10.20127845
resource representing a document's title	At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens
has PubMed Central identifier	PMC7310646
has PubMed identifier	32587988
schema:publication	medRxiv
resource representing a document's body	covid:4b7d38d3d1f303908fc3436c0b59b5a83d01805a#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'diagnosis' named entity 'specimen' named entity 'oropharyngeal' named entity 'LABORATORY' named entity 'PARTICIPANTS' named entity 'respondents' named entity 'specimens' named entity 'traveling' named entity 'collection' named entity 'SARS-CoV-2' named entity 'dried blood spots' named entity 'DBS' named entity 'Likert scale' named entity 'saliva' named entity 'peer review' named entity 'preprint' named entity 'United States' named entity 'global SARS-CoV-2 pandemic' named entity 'preprint' named entity 'April 2020' named entity 'PCR' named entity 'antibody testing' named entity 'public health' named entity 'ethnicity' named entity 'throat swab' named entity 'saliva' named entity 'throat swab' named entity 'healthcare providers' named entity 'laboratory testing' named entity 'oropharyngeal' named entity 'DBS' named entity 'HIV' named entity 'thematic analysis' named entity 'saliva' named entity 'infection status' named entity 'clinical care' named entity 'COVID' named entity 'saliva' named entity '1, 2' named entity 'wasn' named entity 'medRxiv' named entity 'throat swab' named entity 'preprint' named entity 'personal protective equipment' named entity 'CC-BY-NC-ND 4.0' named entity 'preprint' named entity 'OPS' named entity 'preprint' named entity 'testing kits' named entity 'ethnicity' named entity 'SARS-CoV-2' named entity 'PPE' named entity 'COVID' named entity 'preprint' named entity 'SARS-CoV-2' named entity 'stigma' named entity 'PCR testing' named entity 'SARS-CoV-2' named entity 'preprint' named entity 'preprint' named entity 'healthcare workers' named entity 'preprint' named entity 'world's population' named entity 'PCR' named entity 'COVID-19 disease' named entity 'preprint' named entity 'oropharyngeal' named entity 'Emory University' named entity 'DBS' named entity 'human subjects research' named entity 'ethnicity'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software